Literature DB >> 11802771

A novel immunoglobulin superfamily receptor (19A) related to CD2 is expressed on activated lymphocytes and promotes homotypic B-cell adhesion.

John J Murphy1, Paul Hobby, Juan Vilarino-Varela, Benjamin Bishop, Panagiota Iordanidou, Brian J Sutton, John D Norton.   

Abstract

A novel lymphocyte-specific immunoglobulin superfamily protein (19A) has been cloned. The predicted 335-amino-acid sequence of 19A represents a Type 1 membrane protein with homology with the CD2 family of receptors. A molecular model of the two predicted extracellular immunoglobulin-like domains of 19A has been generated using the crystal structure of CD2 as a template. In isolated lymphocytes, expression of 19A is induced by various activation stimuli, and enforced expression of the 19A gene promotes homotypic cell adhesion in a B-cell-line model. Collectively these data imply that the 19A protein plays a role in regulation of lymphocyte adhesion.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11802771      PMCID: PMC1222324          DOI: 10.1042/0264-6021:3610431

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  17 in total

Review 1.  2B4: an NK cell activating receptor with unique specificity and signal transduction mechanism.

Authors:  H Nakajima; M Colonna
Journal:  Hum Immunol       Date:  2000-01       Impact factor: 2.850

Review 2.  Mutational analysis of the epitopes recognized by anti-(rat CD2) and anti-(rat CD48) monoclonal antibodies.

Authors:  S J Davis; E A Davies; P A van der Merwe
Journal:  Biochem Soc Trans       Date:  1995-02       Impact factor: 5.407

3.  Protein fold recognition using sequence-derived predictions.

Authors:  D Fischer; D Eisenberg
Journal:  Protein Sci       Date:  1996-05       Impact factor: 6.725

4.  2B4 functions as a co-receptor in human NK cell activation.

Authors:  S Sivori; S Parolini; M Falco; E Marcenaro; R Biassoni; C Bottino; L Moretta; A Moretta
Journal:  Eur J Immunol       Date:  2000-03       Impact factor: 5.532

5.  Characterization of inhibitory and stimulatory forms of the murine natural killer cell receptor 2B4.

Authors:  J D Schatzle; S Sheu; S E Stepp; P A Mathew; M Bennett; V Kumar
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

6.  Structure of a heterophilic adhesion complex between the human CD2 and CD58 (LFA-3) counterreceptors.

Authors:  J H Wang; A Smolyar; K Tan; J H Liu; M Kim; Z Y Sun; G Wagner; E L Reinherz
Journal:  Cell       Date:  1999-06-11       Impact factor: 41.582

7.  Cell-type-specific early response gene expression during plasmacytoid differentiation of human B lymphocytic leukemia cells.

Authors:  J J Murphy; J D Norton
Journal:  Biochim Biophys Acta       Date:  1990-07-30

8.  The CD2-subset of the Ig superfamily of cell surface molecules: receptor-ligand pairs expressed by NK cells and other immune cells.

Authors:  S G Tangye; J H Phillips; L L Lanier
Journal:  Semin Immunol       Date:  2000-04       Impact factor: 11.130

9.  A novel receptor involved in T-cell activation.

Authors:  B G Cocks; C C Chang; J M Carballido; H Yssel; J E de Vries; G Aversa
Journal:  Nature       Date:  1995-07-20       Impact factor: 49.962

Review 10.  ID helix-loop-helix proteins in cell growth, differentiation and tumorigenesis.

Authors:  J D Norton
Journal:  J Cell Sci       Date:  2000-11       Impact factor: 5.285

View more
  12 in total

Review 1.  The development of potential antibody-based therapies for myeloma.

Authors:  Daniel W Sherbenou; Christopher R Behrens; Yang Su; Jeffrey L Wolf; Thomas G Martin; Bin Liu
Journal:  Blood Rev       Date:  2014-09-28       Impact factor: 8.250

2.  Myeloma-specific multiple peptides able to generate cytotoxic T lymphocytes: a potential therapeutic application in multiple myeloma and other plasma cell disorders.

Authors:  Jooeun Bae; Robert Smith; John Daley; Naoya Mimura; Yu-Tzu Tai; Kenneth C Anderson; Nikhil C Munshi
Journal:  Clin Cancer Res       Date:  2012-07-02       Impact factor: 12.531

3.  SLAMF7 engagement superactivates macrophages in acute and chronic inflammation.

Authors:  Daimon P Simmons; Hung N Nguyen; Emma Gomez-Rivas; Yunju Jeong; A Helena Jonsson; Antonia F Chen; Jeffrey K Lange; George S Dyer; Philip Blazar; Brandon E Earp; Jonathan S Coblyn; Elena M Massarotti; Jeffrey A Sparks; Derrick J Todd; Deepak A Rao; Edy Y Kim; Michael B Brenner
Journal:  Sci Immunol       Date:  2022-02-11

4.  Anti-CS1 humanized monoclonal antibody HuLuc63 inhibits myeloma cell adhesion and induces antibody-dependent cellular cytotoxicity in the bone marrow milieu.

Authors:  Yu-Tzu Tai; Myles Dillon; Weihua Song; Merav Leiba; Xian-Feng Li; Peter Burger; Alfred I Lee; Klaus Podar; Teru Hideshima; Audie G Rice; Anne van Abbema; Lynne Jesaitis; Ingrid Caras; Debbie Law; Edie Weller; Wanling Xie; Paul Richardson; Nikhil C Munshi; Claire Mathiot; Hervé Avet-Loiseau; Daniel E H Afar; Kenneth C Anderson
Journal:  Blood       Date:  2007-09-28       Impact factor: 22.113

5.  CS1 promotes multiple myeloma cell adhesion, clonogenic growth, and tumorigenicity via c-maf-mediated interactions with bone marrow stromal cells.

Authors:  Yu-Tzu Tai; Ender Soydan; Weihua Song; Mariateresa Fulciniti; Kihyun Kim; Fangxin Hong; Xian-Feng Li; Peter Burger; Matthew J Rumizen; Sabikun Nahar; Klaus Podar; Teru Hideshima; Nikhil C Munshi; Giovanni Tonon; Ruben D Carrasco; Daniel E H Afar; Kenneth C Anderson
Journal:  Blood       Date:  2009-02-04       Impact factor: 22.113

6.  Galectin-9 bridges human B cells to vascular endothelium while programming regulatory pathways.

Authors:  Asmi Chakraborty; Caleb Staudinger; Sandra L King; Frances Clemente Erickson; Lee Seng Lau; Angela Bernasconi; Francis W Luscinskas; Chad Perlyn; Charles J Dimitroff
Journal:  J Autoimmun       Date:  2020-12-04       Impact factor: 7.094

7.  High-resolution transcriptome of human macrophages.

Authors:  Marc Beyer; Michael R Mallmann; Jia Xue; Andrea Staratschek-Jox; Daniela Vorholt; Wolfgang Krebs; Daniel Sommer; Jil Sander; Christina Mertens; Andrea Nino-Castro; Susanne V Schmidt; Joachim L Schultze
Journal:  PLoS One       Date:  2012-09-21       Impact factor: 3.240

8.  Glycoprotein structural genomics: solving the glycosylation problem.

Authors:  Veronica T Chang; Max Crispin; A Radu Aricescu; David J Harvey; Joanne E Nettleship; Janet A Fennelly; Chao Yu; Kent S Boles; Edward J Evans; David I Stuart; Raymond A Dwek; E Yvonne Jones; Raymond J Owens; Simon J Davis
Journal:  Structure       Date:  2007-03       Impact factor: 5.006

9.  PDL241, a novel humanized monoclonal antibody, reveals CD319 as a therapeutic target for rheumatoid arthritis.

Authors:  Jacky Woo; Michel P M Vierboom; Hakju Kwon; Debra Chao; Shiming Ye; Jianmin Li; Karen Lin; Irene Tang; Nicole A Belmar; Taymar Hartman; Elia Breedveld; Vladimir Vexler; Bert A 't Hart; Debbie A Law; Gary C Starling
Journal:  Arthritis Res Ther       Date:  2013       Impact factor: 5.156

Review 10.  Mechanisms of NK Cell Activation and Clinical Activity of the Therapeutic SLAMF7 Antibody, Elotuzumab in Multiple Myeloma.

Authors:  Kerry S Campbell; Adam D Cohen; Tatiana Pazina
Journal:  Front Immunol       Date:  2018-11-05       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.